Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huntington Bancshares
HBAN
|
+$233M |
| 2 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$211M |
| 3 |
Amazon
AMZN
|
+$164M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$135M |
| 5 |
Apple
AAPL
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$302M |
| 2 |
CTB
Cooper Tire & Rubber Co.
CTB
|
+$212M |
| 3 |
Ford
F
|
+$181M |
| 4 |
Booking.com
BKNG
|
+$170M |
| 5 |
JPMorgan Chase
JPM
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.39% |
| 2 | Technology | 15.98% |
| 3 | Industrials | 12.96% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Healthcare | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PZN
2626
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $4.75M | ﹤0.01% |
431,054
-3,507
| -0.8% | -$38.7K |
|
|
ZVO
2627
DELISTED
Zovio Inc. Common Stock
ZVO
| $4.74M | ﹤0.01% |
1,831,188
-34,878
| -2% | -$107K |
|
|
FCBP
2628
DELISTED
First Choice Bancorp Common Stock
FCBP
| $4.74M | ﹤0.01% |
155,493
+26,289
| +20% | +$782K |
|
|
USX
2629
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $4.72M | ﹤0.01% |
548,571
+18,560
| +4% | +$197K |
|
2630
Alamos Gold
AGI
$12B
| $4.7M | ﹤0.01% |
614,540
-28,601
| -4% | -$244K |
|
|
HZN
2631
DELISTED
Horizon Global Corporation
HZN
| $4.69M | ﹤0.01% |
553,269
-95,966
| -15% | -$834K |
|
|
BAND
2632
Bandwidth Inc
BAND
$1.18B
| $4.67M | ﹤0.01% |
33,893
-2,215
| -6% | -$278K |
|
|
SURF
2633
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $4.67M | ﹤0.01% |
626,516
+125,002
| +25% | +$963K |
|
2634
Airgain
AIRG
$71.1M
| $4.67M | ﹤0.01% |
226,629
+17,122
| +8% | +$353K |
|
2635
Standard BioTools
LAB
$342M
| $4.63M | ﹤0.01% |
752,285
+33,310
| +5% | +$178K |
|
2636
BayCom
BCML
$335M
| $4.59M | ﹤0.01% |
255,582
+31,937
| +14% | +$580K |
|
2637
Alpha Metallurgical Resources
AMR
$1.77B
| $4.58M | ﹤0.01% |
178,833
+62,325
| +53% | +$1.07M |
|
2638
Kiniksa Pharmaceuticals
KNSA
$6.23B
| $4.57M | ﹤0.01% |
328,214
+90,167
| +38% | +$1.37M |
|
|
LCI
2639
DELISTED
Lannett Company, Inc.
LCI
| $4.57M | ﹤0.01% |
244,644
-26,716
| -10% | -$512K |
|
2640
Value Line
VALU
$333M
| $4.54M | ﹤0.01% |
146,461
-1,905
| -1% | -$58.7K |
|
2641
Iovance Biotherapeutics
IOVA
$2.04B
| $4.54M | ﹤0.01% |
174,294
-16,856
| -9% | -$438K |
|
|
BMTX
2642
DELISTED
BM Technologies, Inc.
BMTX
| $4.52M | ﹤0.01% |
356,122
-10,600
| -3% | -$123K |
|
2643
ACNB Corp
ACNB
$649M
| $4.5M | ﹤0.01% |
161,417
+6,688
| +4% | +$189K |
|
|
SFE
2644
DELISTED
Safeguard Scientifics, Inc.
SFE
| $4.5M | ﹤0.01% |
580,376
-50,159
| -8% | -$342K |
|
2645
ASE Group
ASX
$68.3B
| $4.49M | ﹤0.01% |
558,035
-32,199
| -5% | -$259K |
|
2646
Civeo
CVEO
$356M
| $4.49M | ﹤0.01% |
252,228
+15,077
| +6% | +$252K |
|
|
ADVM
2647
DELISTED
Adverum Biotechnologies
ADVM
| $4.48M | ﹤0.01% |
127,981
-11,863
| -8% | -$639K |
|
2648
Consolidated Water Co
CWCO
$472M
| $4.46M | ﹤0.01% |
379,757
-7,976
| -2% | -$98.6K |
|
|
RVNC
2649
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.44M | ﹤0.01% |
+149,684
| New | +$4.32M |
|
|
ITI
2650
DELISTED
Iteris, Inc.
ITI
| $4.42M | ﹤0.01% |
664,624
+27,586
| +4% | +$186K |
|
Similar funds
Dimensional Fund Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Dimensional Fund Advisors held 3,528 positions worth $316B, up 4.5% from $302B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dimensional Fund Advisors's Q2 2021 filing shows 120 new, 1,436 increased, 1,802 reduced and 67 closed positions. Its largest new stake was Organon & Co: 988,887 shares worth $29.9M. The largest sale was TCF Financial Corporation Common Stock, an estimated $302M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q2 2021 buy was Organon & Co: 988,887 shares worth $29.9M.
- Dimensional Fund Advisors added most to Huntington Bancshares in Q2 2021, an estimated $233M increase.
- Dimensional Fund Advisors's biggest Q2 2021 reduction was Ford, cutting an estimated $181M.
- Dimensional Fund Advisors fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $302M.
- Dimensional Fund Advisors's ten largest holdings make up 10% of its $316B portfolio in Q2 2021.
- Dimensional Fund Advisors opened 120 new positions and closed 67 in Q2 2021.
- Dimensional Fund Advisors's portfolio value rose 4.5% quarter-over-quarter to $316B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.